FDA, COVID-19 and vaccine
Digest more
Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared to other strains on the rise, but it does have a greater ability to bind to human cells, suggesting it could be more transmissible.
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition after vaccination.
Historically, almost everyone has been eligible for Covid vaccines; the C.D.C. recommended the most recent vaccine for all Americans over 6 months of age.
U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period should target newer strains of the JN.1 variant.
Theatre nurse David Collyer wanted to shoot a documentary photography project in the last years of the Welsh hospital he worked in. Then Covid-19 appeared.
Explore more
Health officials are sounding the alarm over a dangerous new COVID-19 strain as hospitalisation rates in China surge. The Centres for Disease Control and Prevention's (CDC) data shows that patients from nine countries have tested positive for the new strain - China, Japan, Vietnam, South Korea, Taiwan, Thailand, France, the Netherlands and Spain.
The researchers analyzed individual outcomes of nearly 13,000 adults hospitalized for COVID who participated in 16 randomized trials comparing JAK inhibitors to other drugs or placebos between May 2020 and March 2022.